Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
13.19
+0.19 (1.48%)
At close: Nov 21, 2025, 4:00 PM EST
12.64
-0.55 (-4.19%)
After-hours: Nov 21, 2025, 4:04 PM EST
Daxor Market Cap
Daxor has a market cap or net worth of $65.76 million as of November 21, 2025. Its market cap has increased by 57.98% in one year.
Market Cap
65.76M
Enterprise Value
66.02M
1-Year Change
57.98%
Ranking
Category
Stock Price
$13.19
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $65.76M, an increase of 117.27%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 65.76M | 76.68% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | 48.61M | 38.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 935.68B |
| Johnson & Johnson | 490.05B |
| AbbVie | 404.90B |
| UnitedHealth Group | 281.47B |
| AstraZeneca | 277.11B |
| Novartis AG | 243.58B |
| Merck & Co. | 233.86B |
| Abbott Laboratories | 216.84B |